ELUTIA INC.
ELUTCIK 0001708527 · Biological Products, (No Diagnostic Substances) · Nasdaq
- AZIYO BIOLOGICS, INC. (until 2023-08-14)
Revenue (TTM)
$15.65M
−15.0% YoY
Q1 Mar 2026
Net Income (TTM)
−$24.88M
+198.9% YoY
Q1 Mar 2026
EPS Diluted (TTM)
−$0.83
+146.8% YoY
Q1 Mar 2026
Gross Margin
51.7%
Q1 Mar 2026
Operating Margin
-180.2%
Q1 Mar 2026
Net Margin
-159.0%
Q1 Mar 2026
Free Cash Flow (TTM)
−$25.45M
Q1 Mar 2026
Cash
$28.49M
Q1 Mar 2026
Total Debt
$26.1M
Q1 Mar 2026
Shares Outstanding
648.68K sh
Q1 Mar 2026